DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 19.60.
| Share Price | ₹7,794.0 | Jul 29,2026 |
| Market Cap | ₹206,930.7 Cr | |
| Sales-TTM | ₹10,560.0 Cr | TTM-Consolidated Results |
| Price/Sales | 19.60x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹206,930.7 Cr] as on Jul 29,2026
(/) Sales [ ₹10,560.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 19.60x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '19.60 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 13.11x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| DIVIS LABORATORIES | 10,560.0 | 19.60 | 206,930.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 8.17 | 477,408.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 13.27 | 185,521.0 |
| CIPLA LTD | 28,324.4 | 4.20 | 119,032.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.87 | 95,420.1 |
| MANKIND PHARMA LTD | 14,277.6 | 7.50 | 107,071.0 |
| LUPIN LTD | 27,958.0 | 4.01 | 112,013.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.12 | 111,960.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.72 | 91,531.1 |
| LAURUS LABS LTD | 7,269.6 | 13.24 | 96,264.7 |
| BIOCON LTD | 16,927.0 | 4.15 | 70,215.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.72x |
| Max industry PS | 19.60x |
| Median industry PS | 4.20x |
| Average industry PS | 7.62x |
You may also like the below Video Courses